Stevanato Group S.p.A. (NYSE:STVN) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Stevanato Group S.p.A. (NYSE:STVN) have earned a consensus recommendation of “Moderate Buy” from the six ratings firms that are currently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company.

Separately, Stephens restated an “overweight” rating and set a $38.00 price target on shares of Stevanato Group in a research report on Monday, March 25th.

Institutional Investors Weigh In On Stevanato Group

Institutional investors have recently bought and sold shares of the stock. Bank of New York Mellon Corp boosted its position in Stevanato Group by 11.4% during the 1st quarter. Bank of New York Mellon Corp now owns 46,717 shares of the company’s stock valued at $940,000 after buying an additional 4,798 shares during the period. BlackRock Inc. boosted its holdings in shares of Stevanato Group by 3.6% during the first quarter. BlackRock Inc. now owns 263,364 shares of the company’s stock worth $5,299,000 after purchasing an additional 9,125 shares during the period. Lazard Asset Management LLC grew its stake in shares of Stevanato Group by 3.4% in the first quarter. Lazard Asset Management LLC now owns 6,366,679 shares of the company’s stock worth $128,097,000 after purchasing an additional 210,007 shares during the last quarter. UBS Group AG increased its holdings in Stevanato Group by 79.9% during the 1st quarter. UBS Group AG now owns 1,799 shares of the company’s stock valued at $36,000 after purchasing an additional 799 shares during the period. Finally, Wellington Management Group LLP raised its position in Stevanato Group by 21.2% during the 1st quarter. Wellington Management Group LLP now owns 992,326 shares of the company’s stock valued at $19,966,000 after purchasing an additional 173,332 shares during the last quarter.

Stevanato Group Price Performance

STVN stock opened at €26.73 ($28.44) on Friday. The company’s 50 day moving average is €30.52 and its 200 day moving average is €29.55. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.50. Stevanato Group has a 1-year low of €23.00 ($24.47) and a 1-year high of €36.30 ($38.62).

Stevanato Group (NYSE:STVN) last released its quarterly earnings results on Thursday, March 7th. The company reported €0.18 ($0.19) EPS for the quarter, missing analysts’ consensus estimates of €0.19 ($0.20) by (€0.01) (($0.01)). The company had revenue of €320.60 million during the quarter, compared to analysts’ expectations of €326.85 million. Stevanato Group had a return on equity of 14.31% and a net margin of 13.43%. Stevanato Group’s quarterly revenue was up 9.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.19 EPS. Analysts expect that Stevanato Group will post 0.67 EPS for the current fiscal year.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.